Clinical Trial Update: Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of adagrasib with stereotactic radiosurgery for metastatic KRAS G12C-mutated non-small cell lung cancer with u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adagrasib (adagrasib)

Snippet

Sponsor: Ryan Gentzler, MD | Conditions: Non Small Cell Lung Cancer, NSCLC | Phase 2 | Status: RECRUITING